Group of leading academics say Humira patent thicketing antitrust issues must be looked at again
Professors seek reversal of original district court decision, following the dismissal of a potential landmark dispute over the nature of sham litigation
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the IAM experts.